Aleksandar Savic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksandar Savic has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ivana Urosevic
3 shared publicationsNebojsa Rajic
3 shared publicationsStevan Popovic
3 shared publicationsVanja Kvrgic
2 shared publicationsAyse Erbay
1 shared publicationBela Balint
1 shared publication
Latest Publications
- 1 April 2012
- Published by Elsevier in Leukemia Research
- Vol. 36 (4) , 479-482
The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients
- 1 April 2012
- Published by Elsevier in Leukemia Research
- Vol. 36 (4) , 479-482
The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients
- 24 January 2012
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 18 (3) , 681-690
Angiogenesis and Survival in Patients with Myelodysplastic Syndrome
- 24 January 2012
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 18 (3) , 681-690
Angiogenesis and Survival in Patients with Myelodysplastic Syndrome
- 1 March 2011
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 28 (1) , 63-67
Treatment of intrathecal methotrexate overdose with folinic acid rescue and lumbar cerebrospinal fluid exchange: A report of two cases
We report two male cases (4- and 5-years-old) of intrathecal methotrexate overdose. The two boys with acute lymphoblastic leukemia were to receive intrathecal injection of methotrexate. Instead of the prescribed 12 mg, they both received a dose of 120 mg. The initial cerebrospinal fluid samples showed methotrexate concentration of 2.24x10-2M in case 1 and 1.32x10-2M in case 2. The cases were successfully treated with cerebrospinal fluid (CSF) exchange and intravenous folinic acid rescue. The favorable outcome in our cases suggests that CSF exchange is safe and that folinic acid rescue may be adequate to prevent sequelae in patients subjected to intrathecal MTX overdoses up to 120 mg. We propose CSF exchange and intravenous folinic acid as the mainstay of treatment. In addition to the staff's failure to check the drug label carefully, the marked resemblance of the two dose preparations of MTX may have been contributory.
- 1 March 2011
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 28 (1) , 63-67
Treatment of intrathecal methotrexate overdose with folinic acid rescue and lumbar cerebrospinal fluid exchange: A report of two cases
We report two male cases (4- and 5-years-old) of intrathecal methotrexate overdose. The two boys with acute lymphoblastic leukemia were to receive intrathecal injection of methotrexate. Instead of the prescribed 12 mg, they both received a dose of 120 mg. The initial cerebrospinal fluid samples showed methotrexate concentration of 2.24x10-2M in case 1 and 1.32x10-2M in case 2. The cases were successfully treated with cerebrospinal fluid (CSF) exchange and intravenous folinic acid rescue. The favorable outcome in our cases suggests that CSF exchange is safe and that folinic acid rescue may be adequate to prevent sequelae in patients subjected to intrathecal MTX overdoses up to 120 mg. We propose CSF exchange and intravenous folinic acid as the mainstay of treatment. In addition to the staff's failure to check the drug label carefully, the marked resemblance of the two dose preparations of MTX may have been contributory.
- 1 December 2010
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 27 (4) , 294-298
Syngeneic peripheral blood stem cell transplantation with immunosuppression for hepatitis-associated severe aplastic anemia
Hepatitis-associated aplastic anemia occurs in up to 10% of all aplastic anemia cases. Syngeneic bone marrow transplantation is rare in patients with severe aplastic anemia and usually requires pre-transplant conditioning to provide engraftment. We report on a 29-year-old male patient with hepatitis-associated severe aplastic anemia who had a series of severe infectious conditions before transplantation, including tracheal inflammation. Life-threatening bleeding, which developed after bronchoscopy, was successfully treated with activated recombinant factor VII and platelet transfusions. Syngeneic peripheral blood stem cell transplantation using immunosuppressive treatment with antithymocyte globulin and cyclosporin A without high-dose pre-transplant conditioning was performed, followed by complete hematologic and hepatic recovery.
- 1 December 2010
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 27 (4) , 294-298
Syngeneic peripheral blood stem cell transplantation with immunosuppression for hepatitis-associated severe aplastic anemia
Hepatitis-associated aplastic anemia occurs in up to 10% of all aplastic anemia cases. Syngeneic bone marrow transplantation is rare in patients with severe aplastic anemia and usually requires pre-transplant conditioning to provide engraftment. We report on a 29-year-old male patient with hepatitis-associated severe aplastic anemia who had a series of severe infectious conditions before transplantation, including tracheal inflammation. Life-threatening bleeding, which developed after bronchoscopy, was successfully treated with activated recombinant factor VII and platelet transfusions. Syngeneic peripheral blood stem cell transplantation using immunosuppressive treatment with antithymocyte globulin and cyclosporin A without high-dose pre-transplant conditioning was performed, followed by complete hematologic and hepatic recovery.